Evidence map›Paper›PMID 39859352›Full record

ArticleInternational journal of molecular sciences2025

António Rajão, João P N Silva, Diana L Almeida-Nunes, Paulo Rompante, Célia Fortuna Rodrigues, José Carlos Andrade

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Probiotic and Postbiotic Interactions ofAntibiotics (Basel, Switzerland) · 2026
    Article
  7. Molecular mechanisms, pathogenesis and therapeutic advances ofFrontiers in cellular and infection microbiology · 2026
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

António RajãoAssociate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.ORCID 0000-0001-5880-4966
João P N SilvaUNIPRO-Oral Pathology and Rehabilitation Research Unit, CESPU, CRL, 4585-116 Gandra, Portugal.ORCID 0000-0003-4455-4286
Diana L Almeida-NunesAssociate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.ORCID 0000-0003-4270-7701
Paulo RompanteUNIPRO-Oral Pathology and Rehabilitation Research Unit, CESPU, CRL, 4585-116 Gandra, Portugal.ORCID 0000-0003-4932-7437
Célia Fortuna RodriguesAssociate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.ORCID 0000-0001-8633-2230
José Carlos AndradeAssociate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.ORCID 0000-0002-2403-6062

Funding

IINFACTS AntiCanPro_PI2RL_IINFACTS_2021
6 · The paper itself

Abstract

Oral candidiasis is one of the most common infections in the immunocompromised. Biofilms of

Indexed as

BiofilmsCandidaCandidiasis, OralLimosilactobacillus reuteriProbioticsCandida albicansHumansMouthantifungal activitybiofilmsCandida spp.oral candidiasisoral probioticsresistance

Identifiers

PMID39859352
PMCPMC11766303

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.